Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Profound Medical Corp. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of PROF: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders4944−5
Shares12.8M12.5M−352.9K (−2.7%)
Value$73.3M$73.7M+$347.5K (+0.5%)

New holders (4)

Institutions that held Profound Medical Corp. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to PROF in Q2 2025
InstitutionSharesValue% of portfolio
First Eagle Investment Management, LLC122,039$720.0K0.00%
Kovitz Investment Group Partners, LLC16,722$98.7K0.00%
Goldman Sachs Group Inc11,595$68.4K0.00%
Carolina Wealth Advisors, LLC2,000$11.8K0.01%

Sold out (9)

Institutions that held Profound Medical Corp. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of PROF in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Altium Capital Management LP360,589$2.10M
Stonepine Capital Management, LLC139,942$814.5K
Chilton Investment Co LLC65,000$378.3K
Marshall Wace, LLP20,801$121.1K
Diametric Capital, LP14,205$82.7K
Millennium Management LLC12,758$74.2K
The PNC Financial Services Group, Inc.11,000$64.0K
Fifth Third Bancorp1,100$6.40K
Signaturefd, LLC400$2.33K